{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:16:50Z","timestamp":1773422210205,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00053","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T05:31:51Z","timestamp":1548307911000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression"],"prefix":"10.3389","volume":"10","author":[{"given":"Ping","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Limou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Binns-Roemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey B.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrmicro1428","article-title":"The trypanolytic factor of human serum","volume":"4","author":"Pays","year":"2006","journal-title":"Nat Rev Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/ki.2015.109","article-title":"APOL1 toxin, innate immunity, and kidney injury","volume":"88","author":"Limou","year":"2015","journal-title":"Kidney Int"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/s0272-6386(00)70259-9","article-title":"Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients","volume":"35","author":"Shahinian","year":"2000","journal-title":"Am J kidney Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/00002030-200402200-00022","article-title":"Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study","volume":"18","author":"Lucas","year":"2004","journal-title":"AIDS"},{"key":"B8","doi-asserted-by":"publisher","first-page":"F1347","DOI":"10.1152\/ajprenal.00717.2012","article-title":"HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor","volume":"304","author":"Chandel","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nrmicro3449","article-title":"HIV-1 and interferons: who's interfering with whom?","volume":"13","author":"Doyle","year":"2015","journal-title":"Nat Rev Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.semnephrol.2017.07.004","article-title":"APOL1 renal risk variants: fertile soil for hiv-associated nephropathy","volume":"37","author":"Kopp","year":"2017","journal-title":"Semin Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12977-016-0296-3","article-title":"Impact of APOL1 polymorphism and IL-1beta priming in the entry and persistence of HIV-1 in human podocytes","volume":"13","author":"Mikulak","year":"2016","journal-title":"Retrovirology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1128\/JVI.02828-13","article-title":"The innate immune factor apolipoprotein L1 restricts HIV-1 infection","volume":"88","author":"Taylor","year":"2014","journal-title":"J Virol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"B14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.279.1.35","article-title":"Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count","volume":"279","author":"Vlahov","year":"1998","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1371\/journal.pgen.0030019","article-title":"Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals","volume":"3","author":"An","year":"2007","journal-title":"PLoS Genet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ajhg.2013.05.014","article-title":"Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations","volume":"93","author":"Ko","year":"2013","journal-title":"Am J Hum Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1681\/ASN.2016050546","article-title":"APOL1-mediated cell injury involves disruption of conserved trafficking processes","volume":"28","author":"Kruzel-Davila","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/cid\/ciu765","article-title":"The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status","volume":"60","author":"Estrella","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1000791","DOI":"10.1371\/journal.pgen.1000791","article-title":"Common genetic variation and the control of HIV-1 in humans","volume":"5","author":"Fellay","year":"2009","journal-title":"PLoS Genet"},{"key":"B20","first-page":"1S","article-title":"Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome","volume":"36","year":"1987","journal-title":"MMWR"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/00002030-200109070-00015","article-title":"Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users","volume":"15","author":"Celentano","year":"2001","journal-title":"AIDS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ng1369","article-title":"Human genes that limit AIDS","volume":"36","author":"O'Brien","year":"2004","journal-title":"Nat Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.chom.2016.02.013","article-title":"Macrophages and HIV-1: an unhealthy constellation","volume":"19","author":"Sattentau","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1742-4690-9-82","article-title":"Macrophages and their relevance in Human Immunodeficiency Virus Type I infection","volume":"9","author":"Koppensteiner","year":"2012","journal-title":"Retrovirology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1053\/j.ajkd.2015.02.329","article-title":"APOL1 genotype and glomerular and tubular kidney injury in women with HIV","volume":"65","author":"Jotwani","year":"2015","journal-title":"Am J Kid Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.kint.2017.11.007","article-title":"Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"93","author":"Swanepoel","year":"2018","journal-title":"Kidney Int"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00053\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T05:31:53Z","timestamp":1548307913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00053\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2019.00053"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00053","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"article-number":"53"}}